Reduction of β-amyloid and γ-secretase by calorie restriction in female Tg2576 mice
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Research indicates that female risk of developing Alzheimer’s disease (AD) is greater than that of males. Moderate reduction of calorie intake, known as calorie restriction (CR), reduces pathology in AD mouse models, and is a potentially translatable prevention measure for individuals at-risk for AD, as well as an important tool for understanding how the brain endogenously attenuates age-related pathology. Whether sex influences the response to CR remains unknown. In this study, we assessed the effect of CR on beta-amyloid peptide (Aβ) pathology and hippocampal CA1 neuron specific gene expression in the Tg2576 mouse model of cerebral amyloidosis. Relative to ad libitum (AL) feeding, CR feeding significantly reduced hippocampal Aβ burden in 15 month old female, but not age-matched male, Tg2576 mice. Sustained CR also significantly reduced expression of presenilin enhancer 2 (Psenen) and presenilin 1 (Ps1), components of the γ-secretase complex, in Tg2576 females. These results indicate that long-term CR significantly reduces age-dependent female Tg2576 Aβ pathology, which is likely to involve CR-mediated reductions in γ-secretase-dependent amyloid precursor protein (APP) metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
Amyloid deposition as the central event in the aetiology of Alzheimer’s disease
Hardy, J., & Allsop, D. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90609-v · Cited by 2,538 · cited 2×
“…2012; Wan et al., 2011), tau aggregation (Chabrier et al., 2012; Oddo et al., 2006), and other types of cellular injury that ultimately drive neuropathology associated with AD (Goedert and Spillantini, 2006; Götz et al., 2009; Hardy and Allsop, 1991; Hyman et al., 1984; von Gunten et al., 2006).”
BackgroundCaloric Restriction Delays Disease Onset and Mortality in Rhesus Monkeys
Colman, R. J., Anderson, R. M., Johnson, S. C., Kastman, E. K., Kosmatka, K. J., Beasley, T. M., Allison, D. B., Cruzen, C., Simmons, H. A., Kemnitz, J. W., et al. (2009) · Science · doi:10.1126/science.1173635 · Cited by 2,277
Alzheimer's disease: cell-specific pathology isolates the hippocampal formation.
Hyman, B. T., Van Hoesen, G. W., Damasio, A. R., & Barnes, C. L. (1984) · Science · doi:10.1126/science.6474172 · Cited by 2,268
The Effect of Retarded Growth Upon the Length of Life Span and Upon the Ultimate Body Size
McCay, C. M., Crowell, M. F., & Maynard, L. A. (1935) · The Journal of Nutrition · doi:10.1093/jn/10.1.63 · Cited by 2,264
Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., & Selkoe, D. J. (1992) · Nature · doi:10.1038/360672a0 · Cited by 1,757 · cited 1×
“…which exhibits age-dependent increases in Aβ plaque load and concomitant memory deficits driven by overexpression of a human APP variant (APPswe) responsible for early-onset AD (Callahan et al., 2001; Citron et al., 1992; Good and Hale, 2007; Hsiao et al., 1996; Mullan et al., 1992).”
BackgroundRegulation of NMDA receptor trafficking by amyloid-β
Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1503 · Cited by 1,561 · cited 4×
“…from sequential processing of the APP holoprotein, induces synaptic dysfunction (Almeida et al., 2005; Hsieh et al., 2006; Jacobsen et al., 2006; Snyder et al., 2005), oxidative damage (Bartley et al., 2012; Wan et al., 2011), tau aggregation (Chabrier et al., 2012; Oddo et al., 2006), and…”
InfluentialMullan, M., Crawford, F., Axelman, K., Houlden, H., Lilius, L., Winblad, B., & Lannfelt, L. (1992) · Nature Genetics · doi:10.1038/ng0892-345 · Cited by 1,513 · cited 2×
“We employed the Tg2576 mouse model of APP overexpression, which exhibits age-dependent increases in Aβ plaque load and concomitant memory deficits driven by overexpression of a human APP variant (APPswe) responsible for early-onset AD (Callahan et al., 2001; Citron et al., 1992; Good and Hale, 2007; Hsiao et al., 1996…”
BackgroundMethodThe efficiency of systematic sampling in stereology—reconsidered
GUNDERSEN, H. J. G., JENSEN, E. B. V., KIÊU, K., & NIELSEN, J. (1999) · Journal of Microscopy · doi:10.1046/j.1365-2818.1999.00457.x · Cited by 1,317
Research works printed but not linked: 64
- Alldred, 2008, Terminal continuation (TC) RNA amplification enables expression profiling using minute RNA input obtained from mouse brain, Int. J. Mol. Sci., 9, 2091, 10.3390/ijms9112091 · DOI · Paper page
- Alldred, 2009, Terminal continuation (TC) RNA amplification without second strand synthesis, J. Neurosci. Methods, 177, 381, 10.1016/j.jneumeth.2008.10.027 · DOI · Paper page
- Alldred, 2012, Microarray analysis of CA1 pyramidal neurons in a mouse model of tauopathy reveals progressive synaptic dysfunction, Neurobiol. Dis., 45, 751, 10.1016/j.nbd.2011.10.022 · DOI · Paper page
- Alldred, 2014, Expression profile analysis of hippocampal CA1 pyramidal neurons in aged Ts65Dn mice, a model of Down syndrome (DS) and Alzheimer's disease (AD), Brain Struct. Funct.
- Azad, 2007, Gender differences in dementia risk factors, Gend. Med., 4, 120, 10.1016/S1550-8579(07)80026-X · DOI · Paper page
- Balducci, 2011, The γ-secretase modulator CHF5074 restores memory and hippocampal synaptic plasticity in plaque-free Tg2576 mice, J. Alzheimers. Dis., 24, 799, 10.3233/JAD-2011-101839 · DOI
- Bartley, 2012, Overexpression of amyloid-β protein precursor induces mitochondrial oxidative stress and activates the intrinsic apoptotic cascade, J. Alzheimers. Dis., 28, 855, 10.3233/JAD-2011-111172 · DOI
- Calhoun, 1998, Hippocampal neuron and synaptophysin-positive bouton number in aging C57BL/6 mice, Neurobiol Aging, 19, 599, 10.1016/S0197-4580(98)00098-0 · DOI · Paper page
- Chow, 2010, An overview of APP processing enzymes and products, Neuromolecular Med., 12, 1, 10.1007/s12017-009-8104-z · DOI · Paper page
- Crump, 2013, Development and mechanism of γ-secretase modulators for Alzheimer's disease, Biochemistry, 52, 3197, 10.1021/bi400377p · DOI · Paper page
- De LaCoste, 1993, The role of cortical connectivity in Alzheimer's disease pathogenesis: a review and model system, Neurobiol. Aging, 14, 1, 10.1016/0197-4580(93)90015-4 · DOI · Paper page
- Dewachter, 2002, Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice, J. Neurosci., 22, 3445, 10.1523/JNEUROSCI.22-09-03445.2002 · DOI · Paper page
- Ding, 2013, Ovariectomy induces a shift in fuel availability and metabolism in the hippocampus of the female transgenic model of familial Alzheimer's, PLoS One, 8, e59825, 10.1371/journal.pone.0059825 · DOI · Paper page
- Esler, 2000, Transition-state analogue inhibitors of gamma-secretase bind directly to presenilin-1, Nat. Cell Biol., 2, 428, 10.1038/35017062 · DOI · Paper page
- Francis, 2002, aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation, Dev. Cell, 3, 85, 10.1016/S1534-5807(02)00189-2 · DOI · Paper page
- Ginsberg, 2005, RNA amplification strategies for small sample populations, Methods, 37, 229, 10.1016/j.ymeth.2005.09.003 · DOI
- Ginsberg, 2008, Transcriptional profiling of small samples in the central nervous system, Methols Mol. Biol., 439, 147, 10.1007/978-1-59745-188-8_10 · DOI · Paper page
- Ginsberg, 2012, Gene expression levels assessed by CA1 pyramidal neuron and regional hippocampal dissections in Alzheimer's disease, Neurobiol. Dis., 45, 99, 10.1016/j.nbd.2011.07.013 · DOI · Paper page
- Ginsberg, 2010, Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer's disease progression, Biol. Psychiatry, 68, 885, 10.1016/j.biopsych.2010.05.030 · DOI · Paper page
- Ginsberg, 2005, Expression profile analysis within the human hippocampus: comparison of CA1 and CA3 pyramidal neurons, J. Comp. Neurol., 487, 107, 10.1002/cne.20535 · DOI · Paper page
- Ginsberg, 2006, Down regulation of Trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease, J. Neurochem., 97, 475, 10.1111/j.1471-4159.2006.03764.x · DOI · Paper page
- Ginsberg, 2000, Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons, Ann. Neurol., 48, 77, 10.1002/1531-8249(200007)48:1<77::AID-ANA12>3.0.CO;2-A · DOI · Paper page
- Goedert, 2006, A century of Alzheimer's disease, Science, 314, 777, 10.1126/science.1132814 · DOI · Paper page
- Golde, 2013, γ-Secretase inhibitors and modulators, Biochim. Biophys. Acta, 1828, 2898, 10.1016/j.bbamem.2013.06.005 · DOI · Paper page
- Good, 2007, The “Swedish” mutation of the amyloid precursor protein (APPswe) dissociates components of object-location memory in aged Tg2576 mice, Behav. Neurosci., 121, 1180, 10.1037/0735-7044.121.6.1180 · DOI · Paper page
- Götz, 2009, Alzheimer's disease selective vulnerability and modeling in transgenic mice, J. Alzheimers. Dis., 18, 243, 10.3233/JAD-2009-1143 · DOI · Paper page
- Goutte, 2002, APH-1 is a multipass membrane protein essential for the Notch signaling pathway in Caenorhabditis elegans embryos, Proc. Natl. Acad. Sci. U. S. A., 99, 775, 10.1073/pnas.022523499 · DOI · Paper page
- Gundersen, 1988, The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use, APMIS, 96, 857, 10.1111/j.1699-0463.1988.tb00954.x · DOI · Paper page
- Gustafson, 2003, An 18-year follow-up of overweight and risk of Alzheimer disease, Arch. Intern. Med., 163, 1524, 10.1001/archinte.163.13.1524 · DOI · Paper page
- Hart, 1999, Adaptive role of caloric intake on the degenerative disease processes, Toxicol. Sci., 52, 3, 10.1093/toxsci/52.2.3 · DOI
- Hemby, 2003, Neuron-specific age-related decreases in dopamine receptor subtype mRNAs, J. Comp. Neurol., 456, 176, 10.1002/cne.10525 · DOI · Paper page
- Hirata-Fukae, 2008, Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model, Brain Res., 1216, 92, 10.1016/j.brainres.2008.03.079 · DOI · Paper page
- Hsiao, 1996, Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice, Science, 274, 7, 10.1126/science.274.5284.99 · DOI · Paper page
- Irizarry, 2001, beta-site APP cleaving enzyme mRNA expression in APP transgenic mice: anatomical overlap with transgene expression and static levels with aging, Am. J. Pathol., 158, 173, 10.1016/S0002-9440(10)63955-7 · DOI
- Kacharmina, 1999, Preparation of cDNA from single cells and subcellular regions, Methods Enzymol., 303, 3, 10.1016/S0076-6879(99)03003-7 · DOI · Paper page
- Kealy, 2002, Effects of diet restriction on life span and age-related changes in dogs, J. Am. Vet. Med. Assoc., 220, 1315, 10.2460/javma.2002.220.1315 · DOI · Paper page
- Klass, 1977, Aging in the nematode Caenorhabditis elegans: major biological and environmental factors influencing life span, Mech. Ageing Dev., 6, 413, 10.1016/0047-6374(77)90043-4 · DOI · Paper page
- Kunzler, 2014, APOE modulates the effect of estrogen therapy on Aβ accumulation, Neurosci. Lett., 560, 131, 10.1016/j.neulet.2013.12.032 · DOI · Paper page
- Lee, 1987, Monoclonal antibodies distinguish several differentially phosphorylated states of the two largest rat neurofilament subunits (NF-H and NF-M) and demonstrate their existence in the normal nervous system of adult rats, J. Neurosci., 7, 3474, 10.1523/JNEUROSCI.07-11-03474.1987 · DOI · Paper page
- Lee, 2002, Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice, Proc. Natl. Acad. Sci. U. S. A., 99, 7705, 10.1073/pnas.092034699 · DOI · Paper page
- Li, 2003, Nicastrin is required for assembly of presenilin/gamma-secretase complexes to mediate Notch signaling and for processing and trafficking of beta-amyloid precursor protein in mammals, J. Neurosci., 23, 3272, 10.1523/JNEUROSCI.23-08-03272.2003 · DOI · Paper page
- Li, 2000, Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1, Nature, 405, 689, 10.1038/35015085 · DOI · Paper page
- Marlow, 2003, APH1, PEN2, and Nicastrin increase Aβ levels and γ-secretase activity, Biochem. Biophys. Res. Commun., 305, 502, 10.1016/S0006-291X(03)00797-6 · DOI
- Mathews, 2002, Calpain activity regulates the cell surface distribution of amyloid precursor protein. Inhibition of calpains enhances endosomal generation of beta-cleaved C-terminal APP fragments, J. Biol. Chem., 277, 36415, 10.1074/jbc.M205208200 · DOI · Paper page
- Mikulca, 2014, Potential novel targets for Alzheimer pharmacotherapy: II. Update on secretase inhibitors and related approaches, J. Clin. Pharm. Ther., 39, 25, 10.1111/jcpt.12112 · DOI · Paper page
- Morales-Corraliza, 2009, In vivo turnover of tau and APP metabolites in the brains of wild-type and Tg2576 mice: greater stability of sAPP in the beta-amyloid depositing mice, PLoS One, 4, e7134, 10.1371/journal.pone.0007134 · DOI · Paper page
- Morrison, 2002, Selective vulnerability of corticocortical and hippocampal circuits in aging and Alzheimer's disease, Prog. Brain Res., 136, 467, 10.1016/S0079-6123(02)36039-4 · DOI · Paper page
- Mouton, 2009, Caloric restriction attenuates amyloid deposition in middle-aged dtg APP/PS1 mice, Neurosci. Lett., 464, 184, 10.1016/j.neulet.2009.08.038 · DOI · Paper page
- Patel, 2005, Caloric restriction attenuates Abeta-deposition in Alzheimer transgenic models, Neurobiol. Aging, 26, 995, 10.1016/j.neurobiolaging.2004.09.014 · DOI · Paper page
- Pedrini, 2009, Dietary composition modulates brain mass and solubilizable Abeta levels in a mouse model of aggressive Alzheimer's amyloid pathology, Mol. Neurodegener., 4, 40, 10.1186/1750-1326-4-40 · DOI · Paper page
- Placanica, 2009, Gender- and age-dependent gamma-secretase activity in mouse brain and its implication in sporadic Alzheimer disease, PLoS One, 4, e5088, 10.1371/journal.pone.0005088 · DOI · Paper page
- Rajendran, 2012, Membrane trafficking pathways in Alzheimer's disease, Traffic, 13, 759, 10.1111/j.1600-0854.2012.01332.x · DOI · Paper page
- Roe, 1995, The Biosure Study: influence of composition of diet and food consumption on longevity, degenerative diseases and neoplasia in Wistar rats studied for up to 30 months post weaning, Food Chem. Toxicol., 33, 1S, 10.1016/0278-6915(94)00139-F · DOI
- Rous, 1914, The influence of diet on transplanted and spontaneous mouse tumors, J. Exp. Med., 20, 433, 10.1084/jem.20.5.433 · DOI · Paper page
- Schmidt, 2012, Abeta measurement by enzyme-linked immunosorbent assay, Methods Mol. Biol., 849, 507, 10.1007/978-1-61779-551-0_34 · DOI · Paper page
- Shiraishi, 2004, PEN-2 enhances gamma-cleavage after presenilin heterodimer formation, J. Neurochem., 90, 1402, 10.1111/j.1471-4159.2004.02597.x · DOI
- Sivilia, 2013, Multi-target action of the novel anti-Alzheimer compound CHF5074: in vivo study of long term treatment in Tg2576 mice, BMC Neurosci., 14, 1, 10.1186/1471-2202-14-44 · DOI
- Steiner, 2002, PEN-2 is an integral component of the gamma-secretase complex required for coordinated expression of presenilin and nicastrin, J. Biol. Chem., 277, 39062, 10.1074/jbc.C200469200 · DOI · Paper page
- Viña, 2010, Why women have more Alzheimer's disease than men: gender and mitochondrial toxicity of amyloid-beta peptide, J. Alzheimers. Dis., 20, S527, 10.3233/JAD-2010-100501 · DOI · Paper page
- Wan, 2011, β-Amyloid peptide increases levels of iron content and oxidative stress in human cell and Caenorhabditis elegans models of Alzheimer disease, Free Radic. Biol. Med., 50, 122, 10.1016/j.freeradbiomed.2010.10.707 · DOI
- Wang, 2005, Caloric restriction attenuates ß-amyloid neuropathology in a mouse model of Alzheimer's disease, FASEB J., 18, 1, 10.1096/fj.04-2370com · DOI · Paper page
- Wolf, 2012, Broad-based nutritional supplementation in 3xTg mice corrects mitochondrial function and indicates sex-specificity in response to Alzheimer's disease intervention, J. Alzheimers. Dis., 32, 217, 10.3233/JAD-2012-120478 · DOI
- Yue, 2005, Brain estrogen deficiency accelerates Aβ plaque formation in an Alzheimer's disease animal model, Proc. Natl. Acad. Sci. U. S. A., 102, 19198, 10.1073/pnas.0505203102 · DOI · Paper page
- Zhang, 2000, Presenilins are required for gamma-secretase cleavage of beta-APP and transmembrane cleavage of Notch-1, Nat. Cell Biol., 2, 463, 10.1038/35017108 · DOI · Paper page
Cited by
Mitophagy and Alzheimer’s Disease: Cellular and Molecular Mechanisms
Kerr, J. S., Adriaanse, B. A., Greig, N. H., Mattson, M. P., Cader, M. Z., Bohr, V. A., & Fang, E. F. (2017) · Trends in Neurosciences · doi:10.1016/j.tins.2017.01.002 · Cited by 870
The effects of aging in the hippocampus and cognitive decline
Bettio, L. E. B., Rajendran, L., & Gil-Mohapel, J. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.04.030 · Cited by 649
Mitophagy in Alzheimer’s disease: Molecular defects and therapeutic approaches
Mary, A., Eysert, F., Checler, F., & Chami, M. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01631-6 · Cited by 244
Bhatti, G. K., Reddy, A. P., Reddy, P. H., & Bhatti, J. S. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00369 · Cited by 145
“A previous study showed that long-term CR significantly reduces β-amyloid and γ-secretase in female Tg2576 mice (Schafer et al., 2015) and plays a preventive role in AD pathology.”
BackgroundCaloric restriction: Beneficial effects on brain aging and Alzheimer’s disease
Van Cauwenberghe, C., Vandendriessche, C., Libert, C., & Vandenbroucke, R. E. (2016) · Mammalian Genome · doi:10.1007/s00335-016-9647-6 · Cited by 121
“Long-term reduced caloric intake provided similar results: attenuation of Ab peptide accumulation and neuritic plaque deposition in the brain of Tg2576 and APP/PS1 mouse models of AD neuropathology after a CR dietary regimen (Mouton et al. 2009; Schafer et al. 2015; Wang et al. 2005).”
BackgroundResult
Metadata
- Authors
- Schafer, M. J., Alldred, M. J., Lee, S. H., Calhoun, M. E., Petkova, E., Mathews, P. M., & Ginsberg, S. D.
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2015-03
- Volume
- 36
- Issue
- 3
- Pages
- 1293-1302
- ISSN
- 0197-4580 (ISSN-L)
- OpenAlex
- W2101531721
- Cited by
- 97
- References
- 31
- FWCI
- 2.72
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Funders
- NIH (GM007238, RR029893, AG043375, AG014449, AG017617, HD057564)
- Alzheimer's Association (IIRG-12–237253)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reduction of β-amyloid and γ-secretase by calorie restriction in female Tg2576 mice. https://app.cochat.ai/papers/10.1016/j.neurobiolaging.2014.10.043
- The paper
- Schafer, M. J., Alldred, M. J., Lee, S. H., Calhoun, M. E., Petkova, E., Mathews, P. M., & Ginsberg, S. D. (2015). Reduction of β-amyloid and γ-secretase by calorie restriction in female Tg2576 mice. Neurobiology of Aging. https://doi.org/10.1016/j.neurobiolaging.2014.10.043
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.